Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors
NCT01342237Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in brain tumor, sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
topotecan
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT01342237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342237.